Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Androgen Replacement to Improve Patient-Important Outcomes in Men With Opioid-Induced Hypogonadism

NCT04798469 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04798469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04798469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Androgen Replacement to Improve Patient-Important Outcomes in Men With Opioid-Induced Hypogonadism
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
January 10, 2022
Completion date
December 30, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism, male, opioid use, pain